key: cord-0963547-0r12f0h3 authors: Herrmann, Jacob; Mori, Vitor; Bates, Jason H.T.; Suki, Béla title: Can Hyperperfusion of Nonaerated Lung Explain COVID-19 Hypoxia? date: 2020-06-01 journal: Res Sq DOI: 10.21203/rs.3.rs-32949/v1 sha: fa193c3d202c95cd20fc2f8f034681d49095ba67 doc_id: 963547 cord_uid: 0r12f0h3 Early stages of the novel coronavirus disease (COVID-19) have been associated with ‘silent hypoxia’ and poor oxygenation despite relatively small fractions of afflicted lung. Although it has been speculated that such paradoxical findings may be explained by impairment of hypoxic pulmonary vasoconstriction in infected lungs regions, no studies have confirmed this hypothesis nor determined whether such extreme degrees of perfusion redistribution are physiologically plausible. Here, we present a mathematical model which provides evidence that the extreme amount of pulmonary shunt observed in patients with early COVID-19 is not plausible without hyperperfusion of the relatively small fraction of injured lung, with three-fold increases in regional perfusion to afflicted regions. Although underlying perfusion heterogeneity (e.g., due to gravity or pulmonary emboli) exacerbated existing shunt in the model, the reported severity of hypoxia in early COVID-19 patients could not be replicated without considerable reduction of vascular resistance in nonoxygenated regions. Gattinoni et al. described disease due to the novel coronavirus (COVID-19) as following 27 two stages, or phenotypes 1 . Patients initially present with a "Type L" phenotype characterized 28 by "Low" lung stiffness (normal compliance averaging 50 mL cmH2O -1 ) despite poor 29 oxygenation. Type L may transition into a frequently fatal "Type H" phenotype characterized by 30 "High" lung stiffness (reduced compliance) accompanied by features reminiscent of 31 conventional acute respiratory distress syndrome (ARDS) 1 . Although a strict dichotomy of 32 phenotypes based on respiratory compliance is controversial 2 , there are nonetheless frequent 33 reports of severe hypoxia in patients with only a small fraction of nonaerated lung 3-5 , including 34 so-called 'silent hypoxia'. Thus the early stages of COVID-19 appear to be unique and poorly 35 understood, manifesting in the lung as peripheral lesions characterized by ground-glass 36 opacification on computed tomography (CT) 6,7 . Curiously, the fraction of lung affected in this 37 way is often surprisingly low given the severity of the associated hypoxia and estimated shunt 38 fractions (average 50%) 8 . If one assumes that ground-glass opacification represents lung that is 39 nonventilated, these CT studies imply abnormally high ratios of shunt fraction to nonaerated lung 40 fraction of 3.0 for COVID-19 compared to 1.3 for ARDS 8 . 41 A possible interpretation of the Type L phenotype is that a disproportionately large 42 fraction of the pulmonary circulation is being directed through nonaerated lung 1,5,8 . Accordingly, 43 Gattinoni et al. hypothesized that their seemingly paradoxical observations of hypoxia and high 44 compliance were related to an underlying impairment of hypoxic pulmonary vasoconstriction 45 (HPV) 8 . Normally, HPV is a feedback mechanism whereby pulmonary arterioles constrict in 46 lung regions with poor oxygenation 9 . This response results in increased regional vascular 47 resistance, reduced regional perfusion, and thereby reduced overall shunt fraction. It seems 48 produced no change in resistance; and 3) "reversed" HPV reduced resistance regardless of 72 Hypoxic pulmonary vasoconstriction (HPV) could be either (b) "normal" with reduced perfusion 80 to regions of low end-capillary oxygen content, (d) "impaired" with no response, or (d) 81 "reversed" with increased perfusion to injured regions. 82 83 The variability in Fshu:Finj with respect to injury location and HPV alterations is shown in 84 Figure 2 . For simplicity, the extent of injury in each simulation was restricted to only 1 height 85 zone: lower, middle, or upper. Normal HPV function results in the lowest pulmonary shunt fractions and lowest degree of hypoxia, preventing PaO2:FiO2 < 300 mmHg % -1 until Finj > 30%. 87 Given a relatively small fraction of injured lung, with Finj ranging from 0 to 30%, both a 88 complete shunt (i.e., zero oxygen uptake) and "reversal" of HPV (i.e., vasodilation in injured 89 focusing the injury in the lower zone (i.e., those with higher baseline perfusion) results in higher 106 Fshu and worse hypoxia. Interestingly, as Finj decreases in the reversed HPV model, the Fshu:Finj 107 ratio increases, indicating that Fshu decreases more slowly than Finj. Note that the impaired HPV 108 model represents unaltered vascular resistances from baseline values, and therefore corresponds 109 to a model with relatively uniform perfusion distribution. 110 The interplay between baseline perfusion gradients and vasodilation in the HPV reversal 111 model is shown in Figure 3 . Baseline perfusion gradient varied between 0 and 100% representing 112 a range of perfusion heterogeneity from uniform with ⅓-⅓-⅓ distribution at 0% gradient to 0-⅓- Our analysis based on a simple mathematical model of perfusion in normal and shunted 131 compartments suggests that the extreme amount of pulmonary shunt observed in patients with 132 early stage severe COVID-19 is not plausible without hyperperfusion of the relatively small 133 fraction of injured lung, with up to 3-fold increases in regional perfusion to the afflicted regions. 134 Furthermore, the obstruction to oxygen diffusion in the injured regions must be nearly complete 135 such that there is less than 5% equilibration between alveolar gas and end-capillary blood. 136 The Type L early stage of COVID-19 described by Gattinoni injured regions (30 to 50%), compared to the 60 to 70% reduction required without considering 204 any physiologic dead space. Another factor that may contribute to systemic hypoxia is increased 205 oxygen uptake by lung tissues, which may account for up to 20% of total oxygen metabolism in 206 patients with lung injury compared to only 5% at baseline 21 . 207 Reports of "silent hypoxia" in early stages of COVID-19 3 may reflect the Type L 208 phenotype. It is intriguing that hypoxia in these patients is not associated with hypercapnia. One 209 might assume that severe pulmonary shunt would produce deficiencies in both oxygen and 210 carbon dioxide exchange. Hypercapnia is less likely to be "silent", considering that even small 211 increases in arterial carbon dioxide tension elicit feedback response from pH-sensitive central 212 chemoreceptors to increase respiratory drive. Although our model suggests that oxygen 213 equilibration must be less than 5% to produce high ratios of Fshu:Finj, it is possible that 214 elimination of carbon dioxide is less impaired given that diffusion of carbon dioxide across the 215 alveolar-capillary membrane is roughly 20-fold faster than that of oxygen 3 . Note that in the normal lung compartments, B was assumed to have a value of 1. where Rinj is resistance of the injured compartment. Note that resistances were defined in a 275 volumetric manner, such that the effective compartmental resistance was inversely proportional 276 to the fraction of lung it represented. Following these HPV modifications and now accounting 277 for an injured compartment at each height level with altered vascular resistance, total pulmonary 278 vascular resistance (PVR) was computed by the parallel combination of compartmental 279 resistances. 280 conducted over a range of Finj from 0 to 30%. For example, 15% of the lower lung zone injured 300 reflects an overall Finj of 5%, because the lower zone represents 1/3 of the total lung. For 301 simplicity, the extent of injury in each simulation was restricted to only 1 height zone: lower, 302 middle, or upper. Baseline perfusion gradient varied between 0 and 100% representing a range of 303 perfusion heterogeneity from uniform with ⅓-⅓-⅓ distribution at 0% gradient to 0-⅓-⅔ 304 distribution at 100% gradient. The degree of limited oxygen diffusion in the injured compartment 305 varied between 0 and 20%, where 0% represents complete shunt and 100% represents complete 306 equilibration with alveolar gas. 307 A Matlab script for evaluating the mathematical model described herein is available as 309 supplementary material. 310 311 COVID-19 pneumonia: Different respiratory treatments for different 313 phenotypes? Subphenotyping 315 ARDS in COVID-19 patients: Consequences for ventilator management COVID-19 patients with respiratory failure: What can we learn 318 from aviation medicine? Critical care crisis and some recommendations during the COVID-19 321 epidemic in China Hypoxaemia related to COVID-19: Vascular and perfusion abnormalities 323 on dual-energy CT Imaging and clinical features of patients with 2019 326 novel coronavirus SARS-CoV-2: A systematic review and meta-analysis Chest CT findings in cases from the cruise ship "Diamond Princess" with 329 coronavirus disease 2019 (COVID-19). Radiol Cardiothorac Imaging Covid-19 does not 332 lead to a 'typical' acute respiratory distress syndrome Hypoxic pulmonary vasoconstriction: From molecular 335 mechanisms to medicine A comparison of inhaled nitric oxide with intravenous vasodilators in the 337 assessment of pulmonary haemodynamics prior to cardiac transplantation Effective control of pulmonary vascular resistance with inhaled 340 nitric oxide after cardiac operation Understanding the renin-angiotensin-aldosterone-SARS-CoV-axis: 342 A comprehensive review Controversies 348 of renin-angiotensin system inhibition during the COVID-19 pandemic Chest CT Features of COVID-19 in Hyperinflammatory shock in children during COVID-19 pandemic Time course of lung changes on chest CT during recovery from 2019 novel 356 coronavirus (COVID-19) pneumonia. Radiology [Online ahead of print COVID-19 and its implications for thrombosis and 359 anticoagulation Respiratory pathophysiology of mechanically ventilated patients with 363 COVID-19: A cohort study Relationship between pulmonary oxygen consumption, lung inflammation, 366 and calculated venous admixture in patients with acute lung injury Treatment of ARDS with prone 369 positioning Early self-proning in awake Patient self-proning with high-374 flow nasal cannula improves oxygenation in COVID-19 pneumonia Distribution of blood flow and ventilation-perfusion ratio in the 377 lung, measured with radioactive CO2 Simple, accurate equations for human blood O2 dissociation 379 computations Acknowledgments 382 Supported by National Heart, Lung, and Blood Institute Grants U01-HL-139466 and R01-HL Author Contributions JH performed experiments and 386 analyzed data. JH, VM, JHTB, and BS interpreted results of experiments, drafted manuscript, 387 edited and revised manuscript, and approved final version of manuscript The authors declare no competing interests.